The company achieved a notable structural turnaround, moving from a negative $2.1 billion equity base in 2023Q4 to a positive $3.0 billion equity position as of 2025Q3.
| Total Assets | 4.26B | 2.78B | 1.52B | 1.08B | 790.33M |
| Asset Growth % | 158.52% | 82.79% | 41.19% | 36.27% | - |
| Total Investment Assets | 4M | 416.22M | 261.82M | 267.82M | 48.47M |
| Long-Term Investments | 52.17M | 0 | 0 | 0 | 0 |
| Short-Term Investments | 3.21B | 416.22M | 261.82M | 267.82M | 48.47M |
| Total Current Assets | 4.1B | 2.67B | 1.41B | 990.58M | 716.95M |
| Cash & Equivalents | 477.57M | 1.9B | 863.12M | 373.56M | 528.87M |
| Receivables | 1.32B | 260.52M | 254.27M | 222.78M | 56.04M |
| Other Current Assets | 41.51M | 16.77M | 13.54M | 118.79M | 72.92M |
| Goodwill & Intangibles | 239.11M | 58.05M | 58.21M | 58.12M | 57.89M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 65.03M | 58.05M | 58.21M | 58.12M | 57.89M |
| PP&E (Net) | 18.21M | 24.23M | 34.68M | 22.97M | 6.77M |
| Other Assets | 18.59M | 17.61M | 17.52M | 5.34M | 8.72M |
| Total Liabilities | 1.27B | 4.41B | 3.66B | 2.96B | 2.28B |
| Total Debt | 11.56M | 19.16M | 31.02M | 24.23M | 3.43M |
| Net Debt | -466.01M | -1.89B | -832.1M | -349.33M | -525.45M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 1.2B | 940.81M | 634.15M | 472.48M | 267.75M |
| Accounts Payable | 14.83M | 10.68M | 17.08M | 9.71M | 4.74M |
| Deferred Revenue | 97.17M | 117.65M | 67.48M | 46.44M | 117.05M |
| Other Current Liabilities | 141.09M | 59.96M | 10.74M | 108.66M | 98.8M |
| Deferred Taxes | 215.34M | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 62.1M | 3.42B | 2.99B | 2.46B | 2B |
| Total Equity | 3B | -1.63B | -2.14B | -1.88B | -1.49B |
| Equity Growth % | 285.01% | 23.56% | -13.67% | -25.86% | - |
| Shareholders Equity | 3B | -1.63B | -2.14B | -1.88B | -1.49B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -180.2M | -1.93B | -2.29B | -1.95B | -1.52B |
| Common Stock | 189K | 71K | 54K | 32K | 16K |
| Accumulated OCI | 13.55M | 99.6M | 15.29M | 11.8M | -5.79M |
| Return on Equity (ROE) | 189.16% | - | - | - | - |
| Return on Assets (ROA) | 35.57% | 40.27% | 15.64% | 2.01% | -55.86% |
| Equity / Assets | 70.27% | -58.78% | -140.56% | -174.59% | -189.03% |
| Debt / Equity | 0.00x | - | - | - | - |
| Book Value per Share | 372.03 | -217.41 | -284.42 | -250.22 | -198.80 |
| Tangible BV per Share | 363.96 | -225.13 | -292.17 | -257.95 | -206.51 |
Regulatory capital adequacy
As indicated by the transition from a negative $2.1 billion equity position in 2023Q4 to a positive $3.0 billion in 2025Q3, Yuanbao has achieved a significant balance sheet turnaround, suggesting that the company is successfully retaining earnings and strengthening its capital base amidst rapid operational scaling.
The shift from persistent negative equity to a robust surplus suggests that the company has moved past its initial capital-intensive startup phase. This trajectory implies that the business model is now generating sufficient internal capital to support its growth without relying on external equity injections.
Based on the latest financial statements, the company's total assets have expanded to $4.3 billion as of 2025Q3, providing a substantial buffer against the $1.3 billion in total liabilities and suggesting a strengthening solvency profile that may support future strategic initiatives or regulatory compliance requirements.
The rapid expansion of the asset base relative to liabilities indicates a significant improvement in the company's net worth. This capital position appears to provide the necessary flexibility to navigate potential regulatory shifts in the Chinese insurance market while maintaining operational continuity.
According to reported figures, claims and loss reserves have increased from $23.2 million in 2022Q4 to $45.1 million in 2025Q3, a trend that appears consistent with the company's expanding policy volume and suggests a disciplined approach to matching reserves with growing insurance exposure.
While the absolute increase in reserves is notable, the relatively low loss ratio of 3.9% in 2025Q3 suggests that the company's underwriting or distribution risk remains well-contained. Investors should monitor whether this reserve growth remains proportional to the underlying policy volume as the company continues to scale.
As noted in the provided data, the investment portfolio remains stagnant at $1.0 million across all reported periods, which may indicate that the company is not actively deploying its capital into income-generating assets, potentially leaving significant cash balances underutilized in a high-growth environment.
The lack of growth in the investment portfolio despite a massive increase in total assets warrants further investigation into where the company is holding its liquidity. This may suggest that the firm is prioritizing extreme liquidity over yield, or that there are structural constraints on how its capital is deployed.
Quick answers to the most common questions about buying YB stock.
As of 2024, Yuanbao Inc. American Depositary Shares (YB) had total assets of $2.78B including $2.67B in current assets.
Yuanbao Inc. American Depositary Shares (YB) carries total debt of $19.2M, offset by $2.32B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Yuanbao Inc. American Depositary Shares (YB) has total shareholders' equity (book value) of $-1633.8M ($-217.41 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Yuanbao Inc. American Depositary Shares (YB) reported a current ratio of 2.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.